肠道菌群与女性生殖疾病的关系研究进展

谢多; 张颖; 张琬琳

doi:10.16766/j.cnki.issn.1674-4152.002737

肠道菌群与女性生殖疾病的关系研究进展

doi: 10.16766/j.cnki.issn.1674-4152.002737

谢多¹,
张颖¹,
张琬琳^2, ,

1.
空军第986医院妇产科，陕西西安 710054
2.
空军军医大学第二附属医院妇产科生殖医学中心，陕西西安 710038

基金项目:

陕西省自然科学基础研究计划项目 2020JQ-456

详细信息

通讯作者:
张琬琳, E-mail: 1843678023@qq.com

中图分类号: R711.7 R378.2
计量
- 文章访问数: 222
- HTML全文浏览量: 158
- PDF下载量: 22
- 被引次数: 0
出版历程
- 收稿日期: 2022-07-21
- 网络出版日期: 2022-12-30

Progress on the relationship between gut microbiota and female reproductive diseases

1.
Department of Obstetrics and Gynecology, Xijing 986 Hospital of Air Force Military Medical University, Xi'an, Shaanxi 710054, China

摘要

摘要: 肠道菌群的形成和增殖始于出生，其组成的改变主要取决于遗传、营养和环境因素。人体肠道内定植着千余种细菌，有高度的多样化。随着高通量测序技术、生物信息学和培养组学的发展，使得研究者能够更深入地探索微生物群的组成及其功能，肠道菌群与人体疾病之间的相关性研究蓬勃开展。肠道菌群在人体的生理、代谢、营养和免疫功能中都起着重要的作用，肠道菌群与宿主之间的微妙平衡影响不同疾病的发展。越来越多的研究聚焦于肠道菌群改变与女性生殖疾病的关联。从动物模型研究到人体研究，目前已有多项研究结果表明肠道菌群整体多样性的改变、特定细菌丰度的变化以及菌群比例的失衡与女性生殖疾病密切相关，如多囊卵巢综合征、子宫内膜异位症、妊娠并发症和不良妊娠结局，但目前对其机制的研究还很有限。以特定肠道菌群或其代谢物为靶点，在女性生殖相关疾病的诊断和治疗的临床研究中已初步展露效果。未来需要进一步地开展机制研究明确肠道菌群与女性生殖相关疾病的因果关系，以及设计更为严谨的临床试验明确有效治疗的标准，为肠道菌群在疾病预防、诊断和治疗中的应用提供更多依据。本文拟对肠道菌群与多囊卵巢综合征、子宫内膜异位症以及复发性流产的关系研究进展进行综述。
- 肠道菌群 /
- 多囊卵巢综合征 /
- 子宫内膜异位症 /
- 复发性流产
Abstract: The formation and proliferation of gut microbiota begin at birth, and its composition changes mainly depending on genetic, nutritional and environmental factors. There are more than thousands of bacteria in the human intestines which are highly diversified. With the development of high-throughput sequencing technology, bioinformatics and culturomics, researchers can deeply explore the composition of the microbiota and their functions. At present, the study on the correlation between gut microbiota and human diseases is booming. Gut microbiota plays an important role in human physiology, metabolism, nutrition and immune function. The delicate balance between gut microbiota and host affects the development of different diseases. An increasing number of studies have focused on the relationship between gut microbiota changes and female reproductive diseases. From animal model research to a human study, various results have shown that the diversity of gut microbiota, the change of species of bacteria abundance and the imbalance of some bacteria proportion, are closely related to female reproductive diseases, such as polycystic ovary syndrome, endometriosis, pregnancy complications and adverse pregnancy outcomes, however, the mechanism is still limited. Targeting specific gut microbiota or its metabolites, results have initially shown effects in the clinical study of diagnosis and treatment of female reproductive-related diseases. Therefore, further mechanism research is needed to clarify the causal relationship between gut microbiota and female reproductive diseases and design more rigorous clinical trials to clarify the standards of effective treatment to provide more basis for the application of gut microbiota in disease prevention, diagnosis and treatment. Thus, this article reviews the research progress on the relationship between intestinal flora and polycystic ovary syndrome, endometriosis and recurrent abortion.
- Gut microbiota /
- Polycystic ovary syndrome /
- Endometriosis /
- Recurrent spontaneous abortion

HTML全文

参考文献(50)

[1]	KORPELA K, DE VOS W M. Early life colonization of the human gut: Microbes matter everywhere[J]. Curr Opin Microbiol, 2018, 44: 70-78. doi: 10.1016/j.mib.2018.06.003
[2]	ADAK A, KHAN M R. An insight into gut microbiota and its functionalities[J]. Cell Mol Life Sci, 2019, 76(3): 473-493. doi: 10.1007/s00018-018-2943-4
[3]	QI X Y, YUN C Y, PANG Y L, et al. The impact of the gut microbiota on the reproductive and metabolic endocrine system[J]. Gut Microbes, 2021, 13(1): 1-21.
[4]	TEEDE H J, MISSO M L, COSTELLO M F, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome[J]. Fertil Steril, 2018, 110(3): 364-379. doi: 10.1016/j.fertnstert.2018.05.004
[5]	ESCOBAR-MORREALE H F. Polycystic ovary syndrome: Definition, aetiology, diagnosis and treatment[J]. Nat Rev Endocrinol, 2018, 14(5): 270-284. doi: 10.1038/nrendo.2018.24
[6]	DONG S T, JIAO J, JIA S S, et al. 16S rDNA full-length assembly sequencing technology analysis of intestinal microbiome in polycystic ovary syndrome[J]. Front Cell Infect Microbiol, 2021, 11: 634981. DOI: 10.3389/fcimb.2021.634981.
[7]	THACKRAY V G. Sex, microbes, and polycystic ovary syndrome[J]. Trends Endocrinol Metab, 2019, 30(1): 54-65. doi: 10.1016/j.tem.2018.11.001
[8]	INSENSER M, MURRI M, DEL CAMPO R, et al. Gut microbiota and the polycystic ovary syndrome: Influence of sex, sex hormones, and obesity[J]. J Clin Endocrinol Metab, 2018, 103(7): 2552-2562. doi: 10.1210/jc.2017-02799
[9]	TORRES P J, SIAKOWSKA M, BANASZEWSKA B, et al. Gut microbial diversity in women with polycystic ovary syndrome correlates with hyperandrogenism[J]. J Clin Endocrinol Metab, 2018, 103(4): 1502-1511. doi: 10.1210/jc.2017-02153
[10]	LIU R, ZHANG C H, SHI Y, et al. Dysbiosis of gut microbiota associated with clinical parameters in polycystic ovary syndrome[J]. Front Microbiol, 2017, 8: 324.
[11]	THURSBY E, JUGE N. Introduction to the human gut microbiota[J]. Biochem J, 2017, 474(11): 1823-1836. doi: 10.1042/BCJ20160510
[12]	LEY R E. Gut microbiota in 2015: Prevotella in the gut: Choose carefully[J]. Nat Rev Gastroenterol Hepatol, 2016, 13(2): 69-70. doi: 10.1038/nrgastro.2016.4
[13]	ZENG B, LAI Z W, SUN L J, et al. Structural and functional profiles of the gut microbial community in polycystic ovary syndrome with insulin resistance (IR-PCOS): A pilot study[J]. Res Microbiol, 2019, 170(1): 43-52. doi: 10.1016/j.resmic.2018.09.002
[14]	ZHANG J C, SUN Z H, JIANG S M, et al. Probiotic bifidobacterium lactis V9 regulates the secretion of sex hormones in polycystic ovary syndrome patients through the gut-brain axis[J]. mSystems, 2019, 4(2). DOI: 10.1128/mSystems.00017-19.
[15]	MALDONADO-GÓMEZ M X, MARTÍNEZ I, BOTTACINI F, et al. Stable engraftment of bifidobacterium longum AH1206 in the human gut depends on individualized features of the resident microbiome[J]. Cell Host Microbe, 2016, 20(4): 515-526. doi: 10.1016/j.chom.2016.09.001
[16]	ZHOU L, NI Z X, CHENG W, et al. Characteristic gut microbiota and predicted metabolic functions in women with PCOS[J]. Endocr Connect, 2020, 9(1): 63-73. doi: 10.1530/EC-19-0522
[17]	QI X Y, YUN C Y, SUN L L, et al. Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome[J]. Nat Med, 2019, 25(8): 1225-1233. doi: 10.1038/s41591-019-0509-0
[18]	GUO J, SHAO J, YANG Y, et al. Gut microbiota in patients with polycystic ovary syndrome: A systematic review[J]. Reprod Sci, 2022, 29(1): 69-83. doi: 10.1007/s43032-020-00430-0
[19]	HE F F, LI Y M. Role of gut microbiota in the development of insulin resistance and the mechanism underlying polycystic ovary syndrome: A review[J]. J Ovarian Res, 2020, 13(1): 73. doi: 10.1186/s13048-020-00670-3
[20]	WANG L, ZHOU J, GOBER H J, et al. Alterations in the intestinal microbiome associated with PCOS affect the clinical phenotype[J]. Biomed Pharmacother, 2021, 133: 110958. DOI: 10.1016/j.biopha.2020.110958.
[21]	王尹瑜, 刘晔, 黄荷凤. 肠道菌群在多囊卵巢综合征发生和发展中的作用[J]. 上海交通大学学报(医学版), 2018, 38(4): 454-457. doi: 10.3969/j.issn.1674-8115.2018.04.019 WANG Y Y, LIU Y, HUANG H F. Roles of gut microbiota in the occurrence and development of polycystic ovary syndrome[J]. Journal of Shanghai Jiaotong University(Medical Science), 2018, 38(4): 454-457. doi: 10.3969/j.issn.1674-8115.2018.04.019
[22]	王璐璐, 朱怡, 胡婷, 等. 生活方式对青春期女性多囊卵巢综合征的疗效评价[J]. 中华全科医学, 2019, 17(4): 590-593. doi: 10.16766/j.cnki.issn.1674-4152.000743 WANG L L, ZHU Y, HU T, et al. Evaluation of lifestyle management on the treatment of adolescent with polycystic ovary syndrome[J]. Chinese Journal of General Practice, 2019, 17(4): 590-593. doi: 10.16766/j.cnki.issn.1674-4152.000743
[23]	AHMADI S, JAMILIAN M, KARAMALI M, et al. Probiotic supplementation and the effects on weight loss, glycaemia and lipid profiles in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial[J]. Hum Fertil (Camb), 2017, 20(4): 254-261. doi: 10.1080/14647273.2017.1283446
[24]	SHOAEI T, HEIDARI-BENI M, TEHRANI H G, et al. Effects of probiotic supplementation on pancreatic β-cell function and c-reactive protein in women with polycystic ovary syndrome: A randomized double-blind placebo-controlled clinical trial[J]. Int J Prev Med, 2015, 6: 27. doi: 10.4103/2008-7802.153866
[25]	HESHMATI J, FARSI F, YOSAEE S, et al. The effects of probiotics or synbiotics supplementation in women with polycystic ovarian syndrome: A systematic review and meta-analysis of randomized clinical trials[J]. Probiotics Antimicrob Proteins, 2019, 11(4): 1236-1247. doi: 10.1007/s12602-018-9493-9
[26]	JAMILIAN M, MANSURY S, BAHMANI F, et al. The effects of probiotic and selenium co-supplementation on parameters of mental health, hormonal profiles, and biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome[J]. J Ovarian Res, 2018, 11(1): 80. doi: 10.1186/s13048-018-0457-1
[27]	GUO Y, QI Y, YANG X, et al. Association between polycystic ovary syndrome and gut microbiota[J]. PLoS One, 2016, 11(4): e0153196. DOI: 10.1371/journal.pone.0153196.
[28]	QI X Y, YUN C Y, LIAO B Y, et al. The therapeutic effect of interleukin-22 in high androgen-induced polycystic ovary syndrome[J]. J Endocrinol, 2020, 245(2): 281-289. doi: 10.1530/JOE-19-0589
[29]	KRIEBS A. IL-22 links gut microbiota to PCOS[J]. Nat Rev Endocrinol, 2019, 15(10): 565. doi: 10.1038/s41574-019-0255-x
[30]	SAUNDERS P T K, HORNE A W. Endometriosis: Etiology, pathobiology, and therapeutic prospects[J]. Cell, 2021, 184(11): 2807-2824. doi: 10.1016/j.cell.2021.04.041
[31]	JOHNSON N P, HUMMELSHOJ L, ADAMSON G D, et al. World Endometriosis Society consensus on the classification of endometriosis[J]. Hum Reprod, 2017, 32(2): 315-324. doi: 10.1093/humrep/dew293
[32]	FLORES R, SHI J X, FUHRMAN B, et al. Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: A cross-sectional study[J]. J Transl Med, 2012, 10: 253. doi: 10.1186/1479-5876-10-253
[33]	BAKER J M, AL-NAKKASH L, HERBST-KRALOVETZ M M. Estrogen-gut microbiome axis: Physiological and clinical implications[J]. Maturitas, 2017, 103: 45-53. doi: 10.1016/j.maturitas.2017.06.025
[34]	BAILEY M T, COE C L. Endometriosis is associated with an altered profile of intestinal microflora in female rhesus monkeys[J]. Hum Reprod, 2002, 17(7): 1704-1708. doi: 10.1093/humrep/17.7.1704
[35]	YUAN M, LI D, ZHANG Z, et al. Endometriosis induces gut microbiota alterations in mice[J]. Hum Reprod, 2018, 33(4): 607-616. doi: 10.1093/humrep/dex372
[36]	CHADCHAN S B, CHENG M, PARNELL L A, et al. Antibiotic therapy with metronidazole reduces endometriosis disease progression in mice: A potential role for gut microbiota[J]. Hum Reprod, 2019, 34(6): 1106-1116. doi: 10.1093/humrep/dez041
[37]	CHADCHAN S B, POPLI P, AMBATI C R, et al. Gut microbiota-derived short-chain fatty acids protect against the progression of endometriosis[J]. Life Sci Alliance, 2021, 4(12). DOI: 10.26508/lsa.202101224.
[38]	ATA B, YILDIZ S, TURKGELDI E, et al. The endobiota study: Comparison of vaginal, cervical and gut microbiota between women with stage 3/4 endometriosis and healthy controls[J]. Sci Rep, 2019, 9(1): 2204. doi: 10.1038/s41598-019-39700-6
[39]	SVENSSON A, BRUNKWALL L, ROTH B, et al. Associations between endometriosis and gut microbiota[J]. Reprod Sci, 2021, 28(8): 2367-2377. doi: 10.1007/s43032-021-00506-5
[40]	HUANG L J, LIU B D, LIU Z H, et al. Gut microbiota exceeds cervical microbiota for early diagnosis of endometriosis[J]. Front Cell Infect Microbiol, 2021, 11: 788836. DOI: 10.3389/fcimb.2021.788836.
[41]	DIMITRIADIS E, MENKHORST E, SAITO S, et al. Recurrent pregnancy loss[J]. Nat Rev Dis Primers, 2020, 6(1): 98. doi: 10.1038/s41572-020-00228-z
[42]	Practice Committee of the American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss: A committee opinion[J]. Fertil Steril, 2020, 113(3): 533-535. doi: 10.1016/j.fertnstert.2019.11.025
[43]	KHOSLA R, WILLOUGHBY C P, JEWELL D P. Crohn's disease and pregnancy[J]. Gut, 1984, 25(1): 52-56. doi: 10.1136/gut.25.1.52
[44]	TERSIGNI C, CASTELLANI R, DE WAURE C, et al. Celiac disease and reproductive disorders: Meta-analysis of epidemiologic associations and potential pathogenic mechanisms[J]. Hum Reprod Update, 2014, 20(4): 582-593. doi: 10.1093/humupd/dmu007
[45]	TERSIGNI C, D'IPPOLITO S, DI NICUOLO F, et al. Recurrent pregnancy loss is associated to leaky gut: A novel pathogenic model of endometrium inflammation?[J]. J Transl Med, 2018, 16(1): 102. doi: 10.1186/s12967-018-1482-y
[46]	夏美艳, 朱敏, 黄亚雄. 子宫内膜微生物群及肠道菌群与复发性流产的相关性分析[J]. 中国妇幼健康研究, 2021, 32(10): 1519-1523. doi: 10.3969/j.issn.1673-5293.2021.10.023 XIA M Y, ZHU M, HUANG Y X. Correlation analysis of endometrial microbiota and intestinal microflora with recurrent spontaneous abortion[J]. Chinese Journal of Woman and Child Health Research, 2021, 32(10): 1519-1523. doi: 10.3969/j.issn.1673-5293.2021.10.023
[47]	徐广立, 赵纪华, 孙艳, 等. 补肾活血汤加减治疗早期不明原因复发性流产肾虚血瘀证的疗效及对肠道菌群的影响[J]. 中国实验方剂学杂志, 2020, 26(4): 102-108. doi: 10.13422/j.cnki.syfjx.20192224 XU G L, ZHAO J H, SUN Y, et al. Efficacy of modified Bushen Huoxuetang on kidney deficiency and blood stasis type early unexplained recurrent abortion and its effect on intestinal flora[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2020, 26(4): 102-108. doi: 10.13422/j.cnki.syfjx.20192224
[48]	JIN M, LI D, JI R, et al. Changes in gut microorganism in patients with positive immune antibody-associated recurrent abortion[J]. Biomed Res Int, 2020, 2020: 4673250. DOI: 10.1155/2020/4673250.
[49]	LIU Y J, CHEN H N, FENG L P, et al. Interactions between gut microbiota and metabolites modulate cytokine network imbalances in women with unexplained miscarriage[J]. NPJ Biofilms Microbiomes, 2021, 7(1): 24. doi: 10.1038/s41522-021-00199-3
[50]	KROG M C, MADSEN M E, BLIDDAL S, et al. The microbiome in reproductive health: Protocol for a systems biology approach using a prospective, observational study design[J]. Hum Reprod Open, 2022, 2022(2): hoac015. DOI: 10.1093/hropen/hoac015.